Business
Half-year Report
Metir PLC reported its unaudited interim results for the six months ended June 30, 2025, revealing significant revenue growth, increasing 828% to £919k from £111k in H1 2024. Microtox® LX instrument sales rose to £368k, up from £40k, and reagent revenue increased to £117k from £41k. The Qatar project contributed £386k in revenue. The gross profit margin remained steady at approximately 38%. Operating expenses were £656k, aligning with the previous year. The adjusted EBITDA loss decreased to £(261k), a 54% improvement. The loss reduced to £(304k). The cash balance was £585k, compared to £982k in the prior period, influenced by a £780k fundraise. A final project payment of £198k is expected within 60 days following Kahramaa's approval in Qatar. Disclaimer*
About this update from Metir Plc
[{"type":"text","content":"\n\n \n30 September 2025\n \nMetir plc\n \n(\"Metir\" or the \"Group\")\n \nInterim Results for the six months ended 30 June 2025\n \nPreparing for growth\n \nMetir plc (AIM: MET), the leading global provider of fast response mobile and point-of-use water and environmental testing technology, today announces its unaudited interim results for the six months ended 30 June 2025 (\"H1 25\"). \n \n\n\n\n\n£'000s\n\n\nH1 25\n\n\nH1 24 *\n\n\n\n\nRevenue\n\n\n919\n\n\n111\n\n\n\n\nGross profit\n\n\n352\n\n\n43\n\n\n\n\nGross margin\n\n\n38.3%\n\n\n38.7%\n\n\n\n\nOperating expenses\n\n\n656\n\n\n674\n\n\n\n\nEBITDA\n\n\n(261)\n\n\n(556)\n\n\n\n\nProfit/(Loss)\n\n\n(304)\n\n\n(631)\n\n\n\n\nCash balance at 30 June\n\n\n585\n\n\n982\n\n\n\n\n \n* H1 24 revenues restated to defer £144k of Qatar CTM revenues to H1 25 to reflect delay in commissioning\n \nFinancial highlights\n \n· Revenue increased 828% to £919k (H1 2024: £111k), reflecting strong sales momentum following the 2024 reset.\n· Microtox® LX instrument sales increased to £368k (H1 2024: £40k).\n· Reagent revenue increased to £117k (H1 2024: £41k), including approximately £26k of reagent revenue from three previously installed and active continuous monitoring (\"CTM\") installations in Hungary and Poland.\n· The flagship Qatar project contributed revenue of £386k, with project CTMs now successfully commissioned.\n· Gross profit margin remained steady at c.38%, with reagents delivering the highest margin at over 70% and LX instruments the lowest margin at 18% (see below).\n· Operating expenses of £656k are in line with the prior year, reflecting the strong control of costs as the business was stabilised.\n· Adjusted EBITDA loss reduced to £(261k), a 54% improvement from the prior year, driven by higher revenues and gross profit.\n· Loss reduced to £(304k), more than halved from the prior year, driven by higher revenues and gross profit.\n· Cash balance of £585k compared to £982k in the prior period as a result of the successful fundraise of £780k on 10 June 2025.\n \nOperational highlights\n \n· Completion of strategic reset in 20...